EcoDrugPlus

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSBSLG00000021508
Gene Symbol: LOC114841833
3 Cross references
215 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSBSLG00000024945
Gene Symbol: LOC114858826
2 Cross references
191 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSBSLG00000014674
Gene Symbol: LOC114844889
3 Cross references
200 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSBSLG00000002505
Gene Symbol: LOC114865890
2 Cross references
195 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSBSLG00000011772
Gene Symbol: LOC114865407
3 Cross references
192 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSBSLG00000013232
Gene Symbol: LOC114842540
3 Cross references
188 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSBSLG00000024005
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSBSLG00000024910
Gene Symbol: DPYD
3 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSBSLG00000009369
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Discoidin Domain-Containing Receptor 2-Like

Ensembl ID : ENSBSLG00000024597
Gene Symbol: LOC114844058
2 Cross references
189 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSBSLG00000003186
Gene Symbol: DRD1B
1 Cross references
200 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSBSLG00000015541
Gene Symbol: DRD2
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).